Copyright Reports & Markets. All rights reserved.

Global Bio-active Peptides Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bio-active Peptides Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Natural Bio-active Peptides
    • 1.3.3 Artificial Synthesis Bio-active Peptides
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bio-active Peptides Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Food
    • 1.4.3 Health Products
    • 1.4.4 Pharmaceutical
    • 1.4.5 Other
  • 1.5 Global Bio-active Peptides Market Size & Forecast
    • 1.5.1 Global Bio-active Peptides Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Bio-active Peptides Sales Quantity (2020-2031)
    • 1.5.3 Global Bio-active Peptides Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Archer Daniels Midland Company
    • 2.1.1 Archer Daniels Midland Company Details
    • 2.1.2 Archer Daniels Midland Company Major Business
    • 2.1.3 Archer Daniels Midland Company Bio-active Peptides Product and Services
    • 2.1.4 Archer Daniels Midland Company Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Archer Daniels Midland Company Recent Developments/Updates
  • 2.2 Seagarden AS
    • 2.2.1 Seagarden AS Details
    • 2.2.2 Seagarden AS Major Business
    • 2.2.3 Seagarden AS Bio-active Peptides Product and Services
    • 2.2.4 Seagarden AS Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Seagarden AS Recent Developments/Updates
  • 2.3 Phermpep
    • 2.3.1 Phermpep Details
    • 2.3.2 Phermpep Major Business
    • 2.3.3 Phermpep Bio-active Peptides Product and Services
    • 2.3.4 Phermpep Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Phermpep Recent Developments/Updates
  • 2.4 Arlak Biotech
    • 2.4.1 Arlak Biotech Details
    • 2.4.2 Arlak Biotech Major Business
    • 2.4.3 Arlak Biotech Bio-active Peptides Product and Services
    • 2.4.4 Arlak Biotech Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Arlak Biotech Recent Developments/Updates
  • 2.5 Naturade
    • 2.5.1 Naturade Details
    • 2.5.2 Naturade Major Business
    • 2.5.3 Naturade Bio-active Peptides Product and Services
    • 2.5.4 Naturade Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Naturade Recent Developments/Updates
  • 2.6 Royal DSM
    • 2.6.1 Royal DSM Details
    • 2.6.2 Royal DSM Major Business
    • 2.6.3 Royal DSM Bio-active Peptides Product and Services
    • 2.6.4 Royal DSM Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Royal DSM Recent Developments/Updates
  • 2.7 MYOS RENS Technology
    • 2.7.1 MYOS RENS Technology Details
    • 2.7.2 MYOS RENS Technology Major Business
    • 2.7.3 MYOS RENS Technology Bio-active Peptides Product and Services
    • 2.7.4 MYOS RENS Technology Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 MYOS RENS Technology Recent Developments/Updates
  • 2.8 Natural Factors Nutritional Products
    • 2.8.1 Natural Factors Nutritional Products Details
    • 2.8.2 Natural Factors Nutritional Products Major Business
    • 2.8.3 Natural Factors Nutritional Products Bio-active Peptides Product and Services
    • 2.8.4 Natural Factors Nutritional Products Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Natural Factors Nutritional Products Recent Developments/Updates
  • 2.9 Valio Oy
    • 2.9.1 Valio Oy Details
    • 2.9.2 Valio Oy Major Business
    • 2.9.3 Valio Oy Bio-active Peptides Product and Services
    • 2.9.4 Valio Oy Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Valio Oy Recent Developments/Updates
  • 2.10 Wuhan Lullaby Pharmaceutical Chemical
    • 2.10.1 Wuhan Lullaby Pharmaceutical Chemical Details
    • 2.10.2 Wuhan Lullaby Pharmaceutical Chemical Major Business
    • 2.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product and Services
    • 2.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
  • 2.11 Wuhan Dahua Pharmaceutical
    • 2.11.1 Wuhan Dahua Pharmaceutical Details
    • 2.11.2 Wuhan Dahua Pharmaceutical Major Business
    • 2.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Product and Services
    • 2.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
  • 2.12 Pharma Foods International
    • 2.12.1 Pharma Foods International Details
    • 2.12.2 Pharma Foods International Major Business
    • 2.12.3 Pharma Foods International Bio-active Peptides Product and Services
    • 2.12.4 Pharma Foods International Bio-active Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Pharma Foods International Recent Developments/Updates

3 Competitive Environment: Bio-active Peptides by Manufacturer

  • 3.1 Global Bio-active Peptides Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Bio-active Peptides Revenue by Manufacturer (2020-2025)
  • 3.3 Global Bio-active Peptides Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Bio-active Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Bio-active Peptides Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Bio-active Peptides Manufacturer Market Share in 2024
  • 3.5 Bio-active Peptides Market: Overall Company Footprint Analysis
    • 3.5.1 Bio-active Peptides Market: Region Footprint
    • 3.5.2 Bio-active Peptides Market: Company Product Type Footprint
    • 3.5.3 Bio-active Peptides Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bio-active Peptides Market Size by Region
    • 4.1.1 Global Bio-active Peptides Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Bio-active Peptides Consumption Value by Region (2020-2031)
    • 4.1.3 Global Bio-active Peptides Average Price by Region (2020-2031)
  • 4.2 North America Bio-active Peptides Consumption Value (2020-2031)
  • 4.3 Europe Bio-active Peptides Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Bio-active Peptides Consumption Value (2020-2031)
  • 4.5 South America Bio-active Peptides Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Bio-active Peptides Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 5.2 Global Bio-active Peptides Consumption Value by Type (2020-2031)
  • 5.3 Global Bio-active Peptides Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 6.2 Global Bio-active Peptides Consumption Value by Application (2020-2031)
  • 6.3 Global Bio-active Peptides Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 7.2 North America Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 7.3 North America Bio-active Peptides Market Size by Country
    • 7.3.1 North America Bio-active Peptides Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Bio-active Peptides Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 8.2 Europe Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 8.3 Europe Bio-active Peptides Market Size by Country
    • 8.3.1 Europe Bio-active Peptides Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Bio-active Peptides Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Bio-active Peptides Market Size by Region
    • 9.3.1 Asia-Pacific Bio-active Peptides Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Bio-active Peptides Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 10.2 South America Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 10.3 South America Bio-active Peptides Market Size by Country
    • 10.3.1 South America Bio-active Peptides Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Bio-active Peptides Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bio-active Peptides Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Bio-active Peptides Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Bio-active Peptides Market Size by Country
    • 11.3.1 Middle East & Africa Bio-active Peptides Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Bio-active Peptides Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Bio-active Peptides Market Drivers
  • 12.2 Bio-active Peptides Market Restraints
  • 12.3 Bio-active Peptides Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bio-active Peptides and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bio-active Peptides
  • 13.3 Bio-active Peptides Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bio-active Peptides Typical Distributors
  • 14.3 Bio-active Peptides Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bio-active Peptides market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
    This report is a detailed and comprehensive analysis for global Bio-active Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Bio-active Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Bio-active Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Bio-active Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Bio-active Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bio-active Peptides
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bio-active Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products, Valio Oy, Wuhan Lullaby Pharmaceutical Chemical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Bio-active Peptides market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Natural Bio-active Peptides
    Artificial Synthesis Bio-active Peptides
    Market segment by Application
    Food
    Health Products
    Pharmaceutical
    Other
    Major players covered
    Archer Daniels Midland Company
    Seagarden AS
    Phermpep
    Arlak Biotech
    Naturade
    Royal DSM
    MYOS RENS Technology
    Natural Factors Nutritional Products
    Valio Oy
    Wuhan Lullaby Pharmaceutical Chemical
    Wuhan Dahua Pharmaceutical
    Pharma Foods International
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Bio-active Peptides product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bio-active Peptides, with price, sales quantity, revenue, and global market share of Bio-active Peptides from 2020 to 2025.
    Chapter 3, the Bio-active Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bio-active Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bio-active Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bio-active Peptides.
    Chapter 14 and 15, to describe Bio-active Peptides sales channel, distributors, customers, research findings and conclusion.

    Buy now